Clinical Trial Update: Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab as maintenance therapy after autologous stem cell transplant in Hodgkin lymphoma patients at relapse/progression risk has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Hodgkin Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2023-06-09